Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Gut Microbial Signatures for Glycemic Responses of GLP-1 Receptor Agonists in Type 2 Diabetic Patients: A Pilot Study

10 Jan 2022

Abstract excerpt

Backgrounds Glucagon-like peptide-1 receptor agonist (GLP-1 RA) is probably one of more effective antidiabetic agents in treatment of type 2 diabetes mellitus (T2D). However, the heterogenicity in responses to GLP-1 RA may be potentially related to gut microbiota, although no human evidence has been published. This pilot study aims to identify microbial signatures associated with glycemic responses to GLP-1 RA....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diabetes Treatment and Management
Share to Gut microbiota and health
Share to Oral microbiology and periodontitis research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35095773
DOI: 10.3389/fendo.2021.814770

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Gut Microbial Signatures for Glycemic Responses of GLP-1 Receptor Agonists in Type 2 Diabetic Patients: A Pilot StudyPMID 35095773Read ↗

Understanding Patterns of the Gut Microbiome May Contribute to an Early Detection and Prevention of Type 2 Diabetes MellitusSemantic proximity Read ↗

Gut Microbiome-Based Diagnostic Model to Predict Diabetes MellitusSemantic proximity Read ↗

Baseline gut microbiome composition predicts metformin therapy short-term efficacy in newly diagnosed type 2 diabetes patientsSemantic proximity Read ↗

Snapshot into the Type-2-Diabetes-Associated Microbiome of a Romanian CohortSemantic proximity Read ↗

Alterations of Gut Microbiota in Type 2 Diabetes Individuals and the Confounding Effect of Antidiabetic AgentsSemantic proximity Read ↗

Gut Bacterial Characteristics of Patients With Type 2 Diabetes Mellitus and the Application PotentialSemantic proximity Read ↗

Characteristics of the gut microbiota in adult patients with type 1 and 2 diabetes based on the analysis of a fragment of 16S rRNA gene using next-generation sequencing.Semantic proximity Read ↗

Functional alterations and predictive capacity of gut microbiome in type 2 diabetesSemantic proximity Read ↗

Bioinformatics analysis of the diversity of gut microbiota and different microbiota on insulin resistance in diabetes mellitus patientsSemantic proximity Read ↗

Fecal Microbiota Composition, Their Interactions, and Metagenome Function in US Adults with Type 2 Diabetes According to EnterotypesSemantic proximity Read ↗

Human Gut Microbiota Changes Reveal the Progression of Glucose IntoleranceSemantic proximity Read ↗

Distinct gut metagenomics and metaproteomics signatures in prediabetics and treatment-naïve type 2 diabeticsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.